What is the prevalence of fear of cancer recurrence in cancer survivors and patients?:A systematic review and individual participant data meta-analysis
Autor: | Yvonne L. Luigjes‐Huizer, Nina M. Tauber, Gerry Humphris, Nadine A. Kasparian, Wendy W. T. Lam, Sophie Lebel, Sébastien Simard, Allan Ben Smith, Robert Zachariae, Yati Afiyanti, Katy J. L. Bell, José A. E. Custers, Niek J. de Wit, Peter L. Fisher, Jacqueline Galica, Sheila N. Garland, Charles W. Helsper, Mette M. Jeppesen, Jianlin Liu, Roxana Mititelu, Evelyn M. Monninkhof, Lahiru Russell, Josée Savard, Anne E. M. Speckens, Sanne J. van Helmondt, Sina Vatandoust, Nicholas Zdenkowski, Marije L. van der Lee |
---|---|
Přispěvatelé: | Medical and Clinical Psychology |
Jazyk: | angličtina |
Rok vydání: | 2022 |
Předmět: |
Male
Adult FEASIBILITY prevalence Stress-related disorders Donders Center for Medical Neuroscience [Radboudumc 13] INVENTORY Experimental and Cognitive Psychology chemical and pharmacologic phenomena MELANOMA PROGRESSION VALIDATION 1117 Public Health and Health Services Cancer Survivors QUALITY-OF-LIFE BREAST-CANCER cancer Humans VERSION Neoplasm Recurrence Local/epidemiology correlates Fear COGNITIVE-BEHAVIOR THERAPY Women's cancers Radboud Institute for Health Sciences [Radboudumc 17] Psychiatry and Mental health fear of recurrence Phobic Disorders oncology CLINICAL-LEVELS Female Neoplasm Recurrence Local |
Zdroj: | Luigjes-Huizer, Y L, Tauber, N M, Humphris, G, Kasparian, N A, Lam, W W T, Lebel, S, Simard, S, Smith, A B, Zachariae, R, Afiyanti, Y, Bell, K J L, Custers, J A E, de Wit, N J, Fisher, P L, Galica, J, Garland, S N, Helsper, C W, Jeppesen, M M, Liu, J, Mititelu, R, Monninkhof, E M, Russell, L, Savard, J, Speckens, A E M, van Helmondt, S J, Vatandoust, S, Zdenkowski, N & van der Lee, M L 2022, ' What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis ', Psycho-Oncology, vol. 31, no. 6, pp. 879-892 . https://doi.org/10.1002/pon.5921 Psycho-Oncology: Journal of the psychological, social and behavioral dimensions of cancer, 31(6), 879-892. Wiley Psycho-Oncology Tauber, N M & Zachariae, R 2022, ' What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis ', Psycho-Oncology . https://doi.org/10.1002/pon.5921 Psycho-Oncology, 31, 6, pp. 879-892 Psycho-Oncology, 31, 879-892 PSYCHO-ONCOLOGY |
ISSN: | 1057-9249 |
Popis: | Contains fulltext : 288352.pdf (Publisher’s version ) (Open Access) OBJECTIVE: Care for fear of cancer recurrence (FCR) is considered the most common unmet need among cancer survivors. Yet the prevalence of FCR and predisposing factors remain inconclusive. To support targeted care, we provide a comprehensive overview of the prevalence and severity of FCR among cancer survivors and patients, as measured using the short form of the validated Fear of Cancer Recurrence Inventory (FCRI-SF). We also report on associations between FCR and clinical and demographic characteristics. METHODS: This is a systematic review and individual participant data (IPD) meta-analysis on the prevalence of FCR. In the review, we included all studies that used the FCRI-SF with adult (≥18 years) cancer survivors and patients. Date of search: 7 February 2020. Risk of bias was assessed using the Joanna Briggs Institute critical appraisal tool. RESULTS: IPD were requested from 87 unique studies and provided for 46 studies comprising 11,226 participants from 13 countries. 9311 respondents were included for the main analyses. On the FCRI-SF (range 0-36), 58.8% of respondents scored ≥13, 45.1% scored ≥16 and 19.2% scored ≥22. FCR decreased with age and women reported more FCR than men. FCR was found across cancer types and continents and for all time periods since cancer diagnosis. CONCLUSIONS: FCR affects a considerable number of cancer survivors and patients. It is therefore important that healthcare providers discuss this issue with their patients and provide treatment when needed. Further research is needed to investigate how best to prevent and treat FCR and to identify other factors associated with FCR. The protocol was prospectively registered (PROSPERO CRD42020142185). |
Databáze: | OpenAIRE |
Externí odkaz: |